Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 8,261,242 5.400% | -186,562 (-2.21%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | Maverick Capital, Ltd. | 25,028,128 3.800% | -8,699,656 (-25.79%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Curis, Inc. CRIS | Maverick Capital, Ltd. | 681,381 8.000% | 99,108 (+17.02%) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | Maverick Capital, Ltd. | 33,727,784 5.200% | 33,727,784 (New Position) | Filing History |
| 2024-11-14 4:30 pm Purchase | 2024-09-30 | 13G | Invivyd, Inc. IVVD | Maverick Capital, Ltd. | 11,765,787 9.900% | 2,421,838 (+25.92%) | Filing History |
| 2024-11-14 4:30 pm Purchase | 2024-09-30 | 13G | Fractyl Health, Inc. Common Stock GUTS | Maverick Capital, Ltd. | 4,248,492 8.900% | 4,248,492 (New Position) | Filing History |
| 2024-02-14 5:12 pm Purchase | 2023-12-31 | 13G | Invivyd, Inc. IVVD | Maverick Capital, Ltd. | 9,343,949 8.500% | 9,343,949 (New Position) | Filing History |
| 2024-02-14 5:03 pm Sale | 2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 0 0.000% | -251,641 (Position Closed) | Filing History |
| 2024-02-14 5:02 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 8,447,804 6.900% | 1,350,140 (+19.02%) | Filing History |
| 2024-02-14 5:01 pm Unchanged | 2023-11-27 | 13D | Global Technology Acquisition Corp. I GTAC | Maverick Capital, Ltd. | 1,200,000 35.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Curis, Inc. CRIS | Maverick Capital, Ltd. | 582,273 9.900% | 582,273 (New Position) | Filing History |
| 2023-05-23 5:23 pm Unchanged | 2023-04-20 | 13D | Global Technology Acquisition Corp. I GTAC | Maverick Capital, Ltd. | 1,200,000 57.400% | 0 (Unchanged) | Filing History |
| 2023-02-14 11:57 am Sale | 2022-12-31 | 13G | Population Health Investment Co., Inc. PHIC | Maverick Capital, Ltd. | 0 0.000% | -1,185,260 (Position Closed) | Filing History |
| 2023-02-14 11:53 am Purchase | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 7,097,664 8.200% | 1,504,275 (+26.89%) | Filing History |
| 2023-02-14 07:38 am Unchanged | 2022-12-31 | 13G | Dragoneer Growth Opportunities Corp. III DGNU | Maverick Capital, Ltd. | 3,000,000 7.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 07:36 am Purchase | 2022-12-31 | 13G | Global Technology Acquisition Corp. I GTAC | Maverick Capital, Ltd. | 1,200,000 6.000% | 1,200,000 (New Position) | Filing History |
| 2023-02-14 07:34 am Unchanged | 2022-12-31 | 13G | Panacea Acquisition Corp. II PANA | Maverick Capital, Ltd. | 1,385,250 7.800% | 0 (Unchanged) | Filing History |
| 2023-02-14 07:34 am Sale | 2022-12-31 | 13G | Coupang, Inc. CPNG | Maverick Capital, Ltd. | 76,202,904 4.800% | -18,591,081 (-19.61%) | Filing History |
| 2023-02-14 07:32 am Sale | 2022-12-31 | 13G | Orion Acquisition Corp. OHPAU | Maverick Capital, Ltd. | 0 0.000% | -2,672,349 (Position Closed) | Filing History |
| 2023-02-14 07:31 am Sale | 2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 251,641 6.600% | -62,592 (-19.92%) | Filing History |